Sengar, M., Vaidyanathan, A., Jain, H., Bagal, B., Nayak, L., Shetty, A., B.S., G., C.S., M., John, A., Eipe, T., Sharma, N., Somaiya, K. (2026). A prospective observational study to compare the efficacy, time toxicity, and cost of conventional 3+7 regimen versus azacitidine + venetoclax (AZA + VEN) as induction therapy in patients with acute myeloid leukemia (AML).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6511